Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A tocopherol and/or actos-controlled clinical trial (NCT05813249) concluded on April 2, 2024, assessing the effects of oral and subcutaneous SEMS on hepatic steatosis and fibrosis improvement in MASLD with T2DM
Facing the impending patent cliff and increased market competition, Merck is actively planning to diversify its product lineup and innovate within its drug development strategy
G., Palma, A
Abstract Obesity, clinically defined by pathological adipose tissue accumulation disrupting metabolic homeostasis, has reached pandemic proportions
US$ 21.85
US$ 23.42
US$ 29.09
US$ 20.34
US$ 23.31
US$ 24.54
US$ 26.72
US$ 24.37
